Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

In this page

Clinical Trial

NCT04423718 Active, Not recruiting
PULSAR

Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration

Phase 3
Interventional

Disease

Disease type

Other

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

11/08/2023

Closing date

27/07/2022

Inclusion criteria :

More

Exclusion criteria :

More

Funding

private

Members involved

Others investigators

Dr Mikk Pauklin

Representative

Estonia

Anterior Segment Rare Eye Diseases (WG4)
See more

Dr Laura Mauring

Substitute

Estonia

Genetic Diagnostics (TWG6), Pediatric Ophthalmology Rare Diseases (WG3), Retinal Rare Eye Diseases (WG1)
See more

Dr Artur Klett

Representative

Estonia

Anterior Segment Rare Eye Diseases (WG4), National Integration (TWG9)
See more

Dr Kristel Harak

Estonia

Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Registries & Epidemiology (TWG7), Retinal Rare Eye Diseases (WG1)
See more

Dr Petra Liskova

Representative

Czech Republic

Anterior Segment Rare Eye Diseases (WG4), Genetic Diagnostics (TWG6), National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Research (TWG8), Retinal Rare Eye Diseases (WG1)
Working Group Leader
See more

Pr Andreas Wedrich

Representative

Austria

See more

Pr Benedetto Falsini

Representative

Italy

See more

Prof Reda ZEMAITIENE

Representative

Lithuania

Anterior Segment Rare Eye Diseases (WG4), National Integration (TWG9), Pediatric Ophthalmology Rare Diseases (WG3)
See more

Dr João Pedro Marques

Substitute

Portugal

National Integration (TWG9), Research (TWG8), Retinal Rare Eye Diseases (WG1)
See more

Dr BERNARDO F. SANCHEZ DALMAU

Representative

Spain

National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Research (TWG8)
See more

ERN EYE member investigating site

HCP : Principal investigators

Center of Clinical Ophthalmic Genetics, Department of Ophthalmology, General University Hospital in Prague, Czech Republic

Adress

U Nemocnice 499/2

128 08 Prague

Czech Republic

Department of ophthalmology, Kepler University Clinic Linz, Linz, Austria

Adress

Kepler Universitätsklinikum GmbHMed Campus II.Krankenhausstraße 7a

4020 Linz

Austria

Hospital of Lithuanian University of Health Sciences, Kauno Klinikos, Kaunas, Lithuania

Adress

Eivenių g. 2

50161 Kaunas

Lithuania